Reduced concentrations of the SCFA acetate have been reported in women with preeclampsia, and perinatal acetate supplementation is sufficient to promote fetal thymic CD4+ T cell and regulatory T cell development in GF mice (37). This evidence concerns the gene CD4 and preeclampsia.